Back to Search
Start Over
Chronotropic incompetence on dobutamine stress echocardiography in candidates for a liver transplant.
- Source :
-
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation [Exp Clin Transplant] 2013 Dec; Vol. 11 (6), pp. 546-53. - Publication Year :
- 2013
-
Abstract
- Objectives: We evaluated dobutamine stress echocardiography as an initial screening test for a cardiac evaluation before a liver transplant.<br />Materials and Methods: We retrospectively examined 111 liver transplant candidates who had undergone previous cardiac evaluation; 30 of whom had undergone a liver transplant.<br />Results: Eighty patients (72.1%) completed a dobutamine stress echocardiography (41 chronotropically competent, 39 incompetent), while 31 patients (27.9%) required us to terminate early. Overall, 68 patients (61%) were on β-blockers (21 required early dobutamine stress echocardiography termination, 30 chronotropically incompetent, and 17 competent). Patient results were normal. Thirty patients underwent a liver transplant. Among candidates requiring termination of early dobutamine stress echocardiography, posttransplant cardiac events included 1 fatal acute myocardial infarction, 1 nonfatal acute myocardial infarction, and 1 idiopathic cardiomyopathy. Among chronotropically incompetent patients, 2 patients had transient bradycardia, and among those who were chronotropically competent, 1 had refractory atrial fibrillation, and 1 had transient bradycardia.<br />Conclusions: Nearly 50% of patients with end-stage liver disease may not reach the target heart rate. Early termination of dobutamine stress echocardiography because of cardiac symptoms or significant echocardiographic changes have more effect in predicting postoperative cardiac events, but further evaluation is required even if their target heart rate is close to that desired. Lower target heart rate may be acceptable in chronotropically incompetent individuals provided they are asymptomatic, have no echocardiographic changes, or cardiovascular risk factors, especially if they are on β-blockers.
- Subjects :
- Adrenergic beta-Antagonists therapeutic use
Bradycardia drug therapy
End Stage Liver Disease physiopathology
Female
Humans
Male
Middle Aged
Myocardial Infarction epidemiology
Preoperative Care
Retrospective Studies
Risk Factors
Treatment Outcome
Bradycardia diagnosis
Bradycardia physiopathology
Echocardiography, Stress
End Stage Liver Disease surgery
Heart Rate physiology
Liver Transplantation
Subjects
Details
- Language :
- English
- ISSN :
- 2146-8427
- Volume :
- 11
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
- Publication Type :
- Academic Journal
- Accession number :
- 24344945
- Full Text :
- https://doi.org/10.6002/ect.2012.0295